Australia markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
7.85+0.05 (+0.64%)
At close: 04:25PM CEST
Currency in NOK

Valuation measures4

Market cap (intra-day) 270.09M
Enterprise value 52.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.04
Enterprise value/revenue N/A
Enterprise value/EBITDA -22.09

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 3-89.63%
S&P500 52-week change 326.24%
52-week high 3178.60
52-week low 36.07
50-day moving average 37.97
200-day moving average 377.68

Share statistics

Avg vol (3-month) 3931.87k
Avg vol (10-day) 3660.35k
Shares outstanding 534.41M
Implied shares outstanding 634.41M
Float 824.19M
% held by insiders 132.08%
% held by institutions 121.20%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-30.15%
Return on equity (ttm)-52.14%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -192.72M
Net income avi to common (ttm)-177.88M
Diluted EPS (ttm)-5.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)220.92M
Total cash per share (mrq)6.42
Total debt (mrq)3.58M
Total debt/equity (mrq)1.38%
Current ratio (mrq)6.58
Book value per share (mrq)7.53

Cash flow statement

Operating cash flow (ttm)-199.41M
Levered free cash flow (ttm)-126.91M